Net Asset Value(s)
04 4월 2024 - 3:00PM
UK Regulatory
Net Asset Value(s)
Net Asset Value(s)
Seneca Growth Capital VCT Plc (the "Company")
4 April 2024
Net asset value (“NAV”)
The Directors and the Investment Manager of the
Company, Seneca Partners Limited (“Seneca”), have reviewed the
valuation of the Company’s Ordinary and B share investment
portfolios and announce an updated NAV for each of the share
classes as at 31 March 2024.
B Shares
As at 31 March 2024, the unaudited NAV per B
share was 63.7p.
This is a decrease of 7.0p from the audited NAV
as at 31 December 2023 of 70.7p, predominantly as a result of AIM
market volatility. The B share NAV as at 31 March 2024 incorporates
changes in the bid prices of the B share pool’s AIM/AQSE quoted
investments combined with the impact of income receivable and
running costs incurred in the period. There have been no material
changes in the valuations of any of the unlisted investments during
the period from 31 December 2023 to the date of this
announcement.
The unaudited NAV total return per B share (NAV
plus cumulative dividends) as at 31 March 2024 was 78.7p.
Ordinary Shares
As at 31 March 2024, the unaudited NAV of an
Ordinary share was 16.8p per share.
This is a decrease of 1.7p from the audited NAV
as at 31 December 2023 of 18.5p and is principally due to a
reduction in the value of the Ordinary share pool’s investment in
AIM quoted Scancell Holdings Plc and a decrease in the Ordinary
share pool’s investment in AIM quoted Arecor Therapeutics Plc. As
at 31 March 2024, shares in Scancell Holdings Plc were valued at
10.0p per share (31 December 2023: 10.5p) and shares in Arecor
Therapeutics Plc were valued at 135.0p per share (31 December 2023:
180p). The Directors also reviewed the unquoted investments held in
the Ordinary share portfolio and concluded that no changes were
required to the carrying value of those investments.
The unaudited NAV total return per Ordinary
share (NAV plus cumulative dividends) as at 31 March 2024 was
90.1p.
The change in NAV for both the B Shares and
Ordinary Shares represents a decrease of 0.1p per share,
respectively, on the unaudited NAVs as at 20 March 2024, announced
on 22 March 2024 and which was included in the Supplementary
Prospectus published by the Company on 28 March 2024.
For the purposes of calculating the unaudited
net asset value per share for both share classes, quoted
investments are carried at closing bid prices as at 31 March 2024
and unquoted investments are carried at fair value as at 31 March
2024.
The number of B shares in issue at 31 March 2024
was 21,780,329 and the number of Ordinary shares was 8,115,376.
Therefore, the total number of voting rights in the Company is
29,895,705.
The B share Offer by the Company remains open
for the 2023/24 tax year until midday today, 4 April 2024 and
shares will be allotted at the above latest published B share
NAV.
This announcement contains inside information as
stipulated under the UK version of the Market Abuse Regulation No
596/2014 which is part of English law by virtue of the European
(Withdrawal) Act 2018, as amended. On publication of this
announcement via a regulatory information service, this information
is considered to be in the public domain.
For further information, please contact:
John Hustler, Seneca Growth Capital VCT Plc
at john.hustler@btconnect.com
Richard Manley, Seneca Growth Capital VCT Plc
at Richard.Manley@senecapartners.co.uk
Any enquiries regarding the offer for
subscription of B shares should be directed to:
Matt Currie at Seneca Partners Limited on 01942
295 981 or at Matt.Currie@senecapartners.co.uk
Seneca Growth Capital Vct (LSE:HYG)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Seneca Growth Capital Vct (LSE:HYG)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
